Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2Gynecologic 2Gastrointestinal 2Other neoplasm 1Dermatologic 1

Conditions

Suspicious Lung Nodules (> 0.5 - 30mm in Longest Diameter, Non-calcified) 1Lymphatic Metastasis 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Methylation × Thoracic × Clear all
NCT07615556 2026-05-29

Circulating Tumor DNA Mutations and Methylation Status as Biomarkers for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules

The University of Hong Kong

Not yet recruiting
200 enrolled
Thoracic

Suspicious Lung Nodules (> 0.5 - 30mm in Longest Diameter, Non-calcified)

NCT06358222 2025-05-18

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Shanghai Chest Hospital

Recruiting
200 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡